Barring Judicial Review is now out in @VandLRev ! I am so excited to have this final version out in the world. Thanks again to the editors and everyone who provided comments on the paper!
https://t.co/b8hopWKq8d
Incredible unforgettable week at #ISICEM24. Hopefully doi:10.1001/jama.2024.2933 can bring us closer to evidence based + personalized medicine. Thank you to @fabio_taccone@jlvincen@seymoc@JAMA_current for inviting us. Don't miss Derek Angus editorial doi:10.1001/jama.2024.0972
TIL is now FDA-approved for patients with advanced melanoma. This is a HUGE deal! Grateful to have had the opportunity to study TIL with the giants at @theNCI, let's continue to move the needle on effective TIL therapies for patients with solid malignancies!
Join us for an exciting pan-UC discussion of all things melanoma. Saturday Feb17th morning. Discussion of what makes melanoma tick and advances in therapy @UCSF@UCSDHealth@UCLAHealth@UCIrvine@UCDavisHealth